22-42060011-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000262.3(NAGA):​c.*268G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000836 in 478,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000061 ( 0 hom. )

Consequence

NAGA
NM_000262.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: -0.0470

Publications

0 publications found
Variant links:
Genes affected
NAGA (HGNC:7631): (alpha-N-acetylgalactosaminidase) NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease). [provided by RefSeq, Jul 2008]
NAGA Gene-Disease associations (from GenCC):
  • alpha-N-acetylgalactosaminidase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • alpha-N-acetylgalactosaminidase deficiency type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • alpha-N-acetylgalactosaminidase deficiency type 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • alpha-N-acetylgalactosaminidase deficiency type 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000262.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGA
NM_000262.3
MANE Select
c.*268G>A
3_prime_UTR
Exon 9 of 9NP_000253.1P17050
NAGA
NM_001362848.1
c.*268G>A
3_prime_UTR
Exon 10 of 10NP_001349777.1P17050
NAGA
NM_001362850.1
c.*268G>A
3_prime_UTR
Exon 10 of 10NP_001349779.1P17050

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGA
ENST00000396398.8
TSL:1 MANE Select
c.*268G>A
3_prime_UTR
Exon 9 of 9ENSP00000379680.3P17050
NAGA
ENST00000898675.1
c.*268G>A
3_prime_UTR
Exon 10 of 10ENSP00000568734.1
NAGA
ENST00000402937.1
TSL:5
c.*268G>A
3_prime_UTR
Exon 10 of 10ENSP00000384603.1P17050

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000613
AC:
2
AN:
326044
Hom.:
0
Cov.:
3
AF XY:
0.0000116
AC XY:
2
AN XY:
172710
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
9546
American (AMR)
AF:
0.00
AC:
0
AN:
15004
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
9842
East Asian (EAS)
AF:
0.00
AC:
0
AN:
19218
South Asian (SAS)
AF:
0.00
AC:
0
AN:
43634
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
18006
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1368
European-Non Finnish (NFE)
AF:
0.0000105
AC:
2
AN:
190870
Other (OTH)
AF:
0.00
AC:
0
AN:
18556
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152198
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41444
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Alpha-N-acetylgalactosaminidase deficiency type 1 (1)
-
1
-
Alpha-N-acetylgalactosaminidase deficiency type 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.0
DANN
Benign
0.47
PhyloP100
-0.047

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886057596; hg19: chr22-42456015; API